PMID- 28275883 OWN - NLM STAT- MEDLINE DCOM- 20180713 LR - 20181113 IS - 1573-6830 (Electronic) IS - 0272-4340 (Linking) VI - 37 IP - 8 DP - 2017 Nov TI - Elevated Plasma Homocysteine Level Increased the Risk of Early Renal Impairment in Acute Ischemic Stroke Patients. PG - 1399-1405 LID - 10.1007/s10571-017-0470-8 [doi] AB - Renal insufficiency is associated with the prognosis of acute ischemic stroke (AIS) and homocysteine (Hcy) levels. This study investigated the association between plasma Hcy levels and renal insufficiency in patients with AIS. A total of 987 patients with AIS who had been treated at the First People's Hospital of Foshan between 2011 and 2014 were retrospectively studied. Based on their cystatin C (Cys C) levels, the patients were divided into the normal renal function group (Cys C 1.25 mg/L). Multivariate regression analysis was applied to reveal the association between hyperhomocysteinemia (HHcy) and renal impairment. The renal impairment group showed more advanced age of onset, higher percentage of prior stroke and hypertension, higher baseline National Institute of Health Stroke Scale score, lower high-density lipoprotein cholesterol levels, and higher Hcy levels compared with the normal renal function group. A multivariate analysis revealed a relationship between early renal impairment and Hcy levels: an increase of Hcy by 1 mumol/L was associated with an increase of 12-18% of the risk of renal impairment among patients with AIS and HHcy. Patients with AIS and HHcy had a 2.42-3.51 fold increase of the risk of renal impairment compared with patients with normal Hcy level (P < 0.001). In conclusion, patients with stroke and HHcy could be more prone to renal impairment. FAU - Chen, Jingjuan AU - Chen J AD - First People's Hospital of Foshan, Foshan, 528000, China. FAU - Li, Guode AU - Li G AD - First People's Hospital of Foshan, Foshan, 528000, China. FAU - Xu, Zuohang AU - Xu Z AD - First People's Hospital of Foshan, Foshan, 528000, China. FAU - Zhang, Chengguo AU - Zhang C AD - First People's Hospital of Foshan, Foshan, 528000, China. zcguo@fsyyy.com. FAU - Wang, Yukai AU - Wang Y AD - First People's Hospital of Foshan, Foshan, 528000, China. FAU - Xie, Haiqun AU - Xie H AD - First People's Hospital of Foshan, Foshan, 528000, China. FAU - Shao, Yan AU - Shao Y AD - First People's Hospital of Foshan, Foshan, 528000, China. FAU - Peng, Lingmei AU - Peng L AD - First People's Hospital of Foshan, Foshan, 528000, China. FAU - Lu, Jiancong AU - Lu J AD - First People's Hospital of Foshan, Foshan, 528000, China. FAU - Yuan, Dahua AU - Yuan D AD - First People's Hospital of Foshan, Foshan, 528000, China. LA - eng PT - Journal Article DEP - 20170308 PL - United States TA - Cell Mol Neurobiol JT - Cellular and molecular neurobiology JID - 8200709 RN - 0 (Biomarkers) RN - 0 (CST3 protein, human) RN - 0 (Cystatin C) RN - 0LVT1QZ0BA (Homocysteine) SB - IM MH - Aged MH - Aged, 80 and over MH - Biomarkers/blood MH - Brain Ischemia/*blood/diagnosis/epidemiology MH - Case-Control Studies MH - China/epidemiology MH - Cystatin C/*blood MH - Female MH - Homocysteine/*blood MH - Humans MH - Hyperhomocysteinemia/blood/diagnosis MH - Kidney Diseases/*blood/diagnosis/epidemiology MH - Male MH - Middle Aged MH - Retrospective Studies MH - Risk Factors MH - Stroke/*blood/diagnosis/epidemiology OTO - NOTNLM OT - Cystatin C OT - Glomerular filtration rate OT - Homocysteine OT - Renal insufficiency OT - Stroke EDAT- 2017/03/10 06:00 MHDA- 2018/07/14 06:00 CRDT- 2017/03/10 06:00 PHST- 2016/08/24 00:00 [received] PHST- 2017/01/31 00:00 [accepted] PHST- 2017/03/10 06:00 [pubmed] PHST- 2018/07/14 06:00 [medline] PHST- 2017/03/10 06:00 [entrez] AID - 10.1007/s10571-017-0470-8 [pii] AID - 10.1007/s10571-017-0470-8 [doi] PST - ppublish SO - Cell Mol Neurobiol. 2017 Nov;37(8):1399-1405. doi: 10.1007/s10571-017-0470-8. Epub 2017 Mar 8.